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Abstract
Background
Coronary artery disease (CAD) is a complex disease and the leading cause of death in the
world. Populations of different ancestry do not always share the same risk markers. Natural
selective processes may be the cause of some of the population differences detected for
specific risk mutations.
Objective
In this study, 384 single nucleotide polymorphisms (SNPs) located in four genomic regions
associated with CAD (1p13, 1q41, 9p21 and 10q11) are analysed in a set of 19 populations
from Europe, Middle East and North Africa and also in Asian and African samples from the
1000 Genomes Project. The aim of this survey is to explore for the first time whether the
genetic variability in these genomic regions is better explained by demography or by natural
selection.
Results
The results indicate significant differences in the structure of genetic variation and in the LD
patterns among populations that probably explain the population disparities found in mark-
ers of susceptibility to CAD.
Conclusions
The results are consistent with potential signature of positive selection in the 9p21 region
and of balancing selection in the 9p21 and 10q11. Specifically, in Europe three CAD risk
markers in the 9p21 region (rs9632884, rs1537371 and rs1333042) show consistent signals
of positive selection. The results of this study are consistent with a potential selective role of
CAD in the configuration of genetic diversity in current human populations.
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Introduction
Coronary artery disease (CAD) is a complex disease and the main cause of death in the world.
In 2007, the first genome-wide significant risk region, 9p21, was simultaneously discovered
by two independent groups [1, 2] and was subsequently confirmed by multiple investigators
around the world. Currently, there are a total of 50 variants predisposing to CAD of genome-
wide significance confirmed in independent populations [3]. Out of these 50 risk loci, 15 are
associated with conventional risk factors for CAD: seven with low-density lipoprotein-choles-
terol (LDL-C); one with high-density lipoprotein (HDL); two with triglycerides; four with
hypertension, and one with coronary thrombosis. The remaining 35 variants operate through
mechanisms yet to be determined [3].
Most genome wide association studies (GWAS) for CAD have been performed on popula-
tions of European descent, but increasing numbers of such investigations are now performed
also on populations of Asian or African ancestry. In the literature currently available, some of
the genetic effects observed are shared among ethnic groups but many times genetic effects are
different across populations of different ancestry. The latter is the case of the 9p21 locus,
which has been documented in Europeans and also in other ethnic groups including East and
South Asians, but not among African Americans [4]. Demography and selection are the most
important evolutionary forces that shape the population-specific patterns of mutations and
linkage disequilibrium (LD) identified across populations of different ancestry. Demographic
phenomena such as population expansions, subdivisions and bottleneck events could underlie
differences among populations in a uniform way across genes. On the other hand, there are
evolutionary processes with locus-specific effects. The genetic basis of common complex
diseases may have partially been shaped by positive selection events, which simultaneously
increased fitness and susceptibility to the disease. An additional difficulty to detect the role of
selection is that methods to detect it have historically been challenged by the confounding
effects of demography [5]. In any case, examples of positive selection have been identified in
complex diseases such as type 1 diabetes, rheumatoid arthritis, or Crohn’s disease [6].
Concerning CAD risk regions, in the current literature there are discrepancies regarding
the role of natural selection. A recent survey proposed natural selection as a possible explana-
tion for the observed differences between Africa, East Asia, America, and Oceania in risk allele
frequencies (RAFs) for eight CAD risk single nucleotide polymorphisms (SNPs) [7]. Another
study reported evidence for selection at several SNPs identified through GWAS on sets of
genes implicated in cardiovascular diseases [8]. In addition, Soranzo et al. identified one haplo-
type in a region of long-range LD (12q24) that contains disease loci for CAD, hypertension
and type I diabetes, and that recently spread by positive selection in Europeans [9]. On the con-
trary, a recent survey affirmed that genetic differences for CAD among world-wide populations
are due to random and demographic processes [6]. However, the conclusions of this last paper
were not demonstrated through the use of different methodological approaches. Indeed, the
authors used two tests (iHS and LRH) exclusively based on the same class of analytical method
(LD decay) to search for signals of selection in CAD risk loci. Despite all the studies performed
so far, the genetic architecture of CAD is not completely understood yet. In CAD, as in any
complex trait, risk variants at many different loci may contribute to the phenotype each with a
small effect. By combining evidence from GWAS with evidence from selection scans, it may be
possible to separate true causative regions from the background noise inherent in GWAS [8].
The role that natural selection plays in CAD population differentiation may be a good tool to
improve the knowledge of this complex trait.
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Population differences in risk loci associated to CAD were recently detected for the 1p13,
1q41, 9p13, and 10q11 regions. These genomic regions showed disparities in the specific risk
markers associated with CAD between European and North African samples [10].
The present work is centred on these four genetic regions (1p13, 1q41, 9p21 and 10q11) to
explore whether the population genetic diversity is better explained by demographic or by nat-
ural selection effects.
To do this, we have analysed these risk regions in a set of North European and Mediterra-
nean populations. Several specific tests to detect positive and/or balancing selection were
performed. In addition, these analyses were expanded to populations from Asia and Africa
looking for signatures of selection shared across continents or belonging to a specific popula-
tion group.
Materials and Methods
Ethics statement
The study has been specifically approved by the Ethical Committee of the University of Barce-
lona (Institutional Review Board: IRB00003099) and all the participants provided a written
informed consent.
Sample description
Nineteen population samples from Europe, Middle East and North Africa were genetically
tested. DNA samples of 868 healthy unrelated individuals of both sexes having their relatives
for at least three generations born in the same geographical region were analyzed.
Population details of all samples, including sample size, geographic origin and coordinates
are recorded in S1 Table. The geographic distribution of the analyzed samples is displayed in
Fig 1. Europe is represented by samples from Poland, Spain (4 populations), France (2 popula-
tions), Italy (2 populations), Bosnia-Herzegovina, Greece, and Turkey. The Middle East is rep-
resented by two populations from Jordan and the North African area is represented by samples
from Tunisia, Morocco (2 populations), Algeria and Libya. Genetic data from European (CEU,
GBR, FIN, and TSI), Sub-Saharan African (LWK and YRI) and Asian (JPT and CHB) samples
from the 1000 Genomes Project [11] were also included in the analyses (S1 Table).
Polymorphisms and genotyping
Genomic DNA was extracted from blood cells using a Blood Midi kit (Omega Biotek, USA)
according to manufacturer's procedures. DNA samples were genotyped for a combined set of
384 SNPs using a Custom GoldenGate Panel (Illumina Inc., San Diego, CA). These polymor-
phisms were located in four loci previously associated and replicated in independent studies
with CAD [12, 3, 13, 14, 15], specifically the 1p13 (61SNPs), 1q41 (38 SNPs), 9p21 (159 SNPs),
and 10q11 (126 SNPs) chromosomal regions.
SNPs were selected as a representative set of the common variation in the four genomic
regions, according to the following criteria: i) average coverage of 1 SNP every 1.5 kb, ii) minor
allele frequency (MAF) higher than 0.05 in CEU and TSI HapMap populations, iii) given prior-
ity to markers not in linkage disequilibrium (LD) (r2<0.8) in European populations, and iv)
prioritizing markers previously associated with CAD [4]. These criteria were applied giving
preference to tag SNPs. Genomic location of genetic variants is shown in S2 Table.
In addition, all the variation concerning these four genomic regions reported in the 1000
Genomes Project was used to perform three specific selection analyses: Tajima’s D, Long
Range Haplotype (LRH) test and FST tests.
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Data Cleaning and Quality Control
Genotyping rate per SNP and individual, cryptic relatedness, and LD pruning (r20.8) were
assessed using PLINK version 1.07 [16]. Individuals with more than 5% of missing genotypes
were eliminated. Non-polymorphic SNPs or SNPs with genotyping rate lower than 0.95 were
also removed from the analyses.
Population allele frequencies and heterozygosity calculations were performed using Pop-
Genkit R software package [17]. Fitting to Hardy-Weinberg equilibrium in each population
was calculated by means of Arlequin v3.5 software [18].
Population Structure Analyses
Genetic structure was assessed by molecular variance (AMOVA) using Wright's F-statistics in
the European and Mediterranean area and, in a broader context, in the European, African and
Asian continents. Populations were clustered according to geographic criteria. Middle Eastern
samples were clustered into the South European group due to affinities in their genetic dis-
tances. The samples were clustered in: 1) North Europe, South Europe, and North Africa, and
2) North Europe, South Europe, North Africa, Sub-Saharan Africa and Asia. AMOVAs were
carried out using Arlequin v3.5 [18].
Genetic relationships among populations were assessed by Reynolds genetic distance and by
a principal component (PC) analysis calculated through the Adegenet [19] and FactoMineR R
packages [20].
The LD blocks based on the LD measure D0 confidence interval [21] were performed in the
four genomic regions using Haplot software [22]. These analyses were performed twice: first,
considering all markers in all samples and, second, taking into account only the chromosomal
fragments where markers previously associated in Europeans [21, 13, 22], Africans [10, 23, 24]
Fig 1. Geographic distribution of European, African and Asian samples. See S1 Table for abbreviation codes. Symbols: “&” samples genotyped in this
study, “+” data from the 1000 Genomes Project.
doi:10.1371/journal.pone.0134840.g001
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and Asians [25] are located. Permutation procedures to obtain a Monte Carlo statistical signifi-
cance were used for each chromosomal region in order to evaluate population differences in
LD structure through the VarLD software version 1.0 [26]. This analysis was carried out using
150 randomly selected individuals for each different population group (North Europe, South
Europe, North Africa, Sub-Saharan Africa, and Asia) to avoid biases due to differences in sam-
ple size. The LD statistics (D’ and r2) for each pair of risk SNPs in each population analyzed
were calculated through the Haploview software version 4.2 [27].
Selection Analyses
Detection of potential loci under selection was assessed using different methods. The first
method used is based on the probability of observing locus by locus AMOVA statistics as a
function of heterozygosity, given a null distribution generated under a hierarchically-struc-
tured island model of population differentiation [28]. This test detects loci under selection
from genome scans that contrast patterns of genetic diversity within and between populations.
A total of 20000 coalescent simulations in 50 groups, with 100 simulated demes per group were
performed. The observed locus-specific measures of population differentiation (FST) were com-
pared to a null distribution obtained by simulation samples. The P-value of each locus was esti-
mated from the joint distribution of heterozygosity and FST using a kernel density estimation
procedure. The null distribution generated was summarized by quantiles of the joint distribu-
tion. The 1% and 99% quantiles of the distribution correspond to markers potentially under
balancing or directional selection, respectively, at the 1% level, without multiple-test correction
and assuming one-tailed test. This method was performed using Arlequin v3.5 software [18].
Moreover, the spatial ancestry (SPA) analysis was used to detect positive signatures of
selection [29]. In this analysis, SNP data were used to model allele frequency distributions in a
geographic space. Applying the SPA approach, polymorphisms showing steep geographic gra-
dients in allele frequencies can be identified through SPA scores reflecting the steepness of the
geographic gradient. Large SPA scores are indicators of potential selection. In this study we
focused on SPA scores above the 99th percentile, based on the 367 SNPs analysed. In order to
detect continental adaptation events, analyses were performed only in Europe and North
Africa. Asian and Sub-Saharan African samples were not tested for the SPA scores due to the
low number of available populations for these geographic regions.
Spatial distribution of mean MAF for one of the three CAD SNPs potentially positively
selected across populations was mapped using the geostatistical method known as kriging from
the ArcGIS software (ESRI, Redlands, CA, USA). Since anisotropy was not detected in the
semivariogram, we used the ordinary spherical interpolation kriging method [30]. Finally, the
Tajima’s D [31], the extended haplotype homozygosity (EHH) and the cross-continental FST
tests were conducted in three populations of the larger dataset of the 1000 Genomes Project
(CEU, CHB, and YRI) through the web tool 1000 Genome Selection Browser 1.0 [32]. The
Tajima’s D test was performed using windows of 3-kb to search signatures of balancing selec-
tion. The EHH test was applied to validate loci under positive selection found in previous tests,
using a larger chromosome region of 20-Mb. The significance of the three tests was assessed by
the rank score tracks, which provided a comparison to the rest of the genome, calculated by
means of the web tool 1000 Genome Selection Browser 1.0 [32]. They were calculated by
empirical comparisons sorting all the scores genome-wide and determining the-log10 of the
rank divided by the number of values in the distribution, taking the upper tail for the FST and
the EHH tests, and the lower tail for the Tajima’s D test. The p-values were assigned on the
basis of the rank score tracks. In this study, Tajima’s D, EHH average and FST scores above the
95th percentile of the top extreme genome-wide distribution were considered as significant. All
Natural Selection and Coronary Artery Disease
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p-values were corrected for multiple comparisons applying the false discovery rate (FDR)
method [33] by means of the stats R package [17].
Results
Genotyping and quality control
After pruning, the average coverage was 1 SNP every 1.8 Kb. Genotyping rate for the 384 SNPs
initially tested was 95.8%. Sixteen SNPs were not successfully genotyped and were removed
from the study. One SNP showed a significant departure from Hardy-Weinberg equilibrium
after Bonferroni correction. Thus, a total of 367 markers were included in the analyses after
quality control: 59 SNPs in 1p13 (S1 Fig), 37 in 1q41 (S2 Fig), 155 in 9p21 (S3 Fig), and 116 in
10q11 (S4 Fig). Moreover, twenty individuals were removed for low genotyping rate (>5% of
missing genotypes); consequently, 848 population samples were analysed. Individual genotypes
are included in S1 Dataset. For PC and for Reynolds genetic distance analyses, a total of 176
SNPs were removed due to high LD (r2>0.8) hence, only 190 SNPs were included in popula-
tion relationship analyses.
Levels of diversity and population relationships
The SNP minor allele frequencies (MAF) in population samples and global heterozygosities
per marker and population are presented in S2 Table. Mean heterozygosities per SNP were
moderate-high, ranging from 0.038 to 0.495. Per population, heterozygosities ranged from
0.259 to 0.345.
Hierarchical AMOVA estimates when populations were clustered in North Europe, South
Europe, North Africa, Sub-Saharan Africa and Asia were FST = 0.085 and FCT = 0.080 (both
p<0.0001). When Sub-Sahara African and Asian data were removed and the remaining popu-
lations were grouped in North Europe, South Europe and North Africa, AMOVA estimates
were FST = 0.017 and FCT = 0.012 (both p<0.0001). These values indicate a statistically signifi-
cant geographic structure of genetic variation in the three continents, and also across Europe
and North Africa.
Population genetic distances are indicated in S3 Table. The highest average genetic distance
was among North African and European samples (0.170±0.031). The genetic distance between
Middle East and North Africa was higher (0.156±0.032) with respect to Europe (0.141±0.023).
Concerning population relationships, in the PC analysis (Fig 2) of the European, North
African and Middle East populations, the two first axes accounted for 38.31% of the total
genetic variance. In the first axis (24.99% of the total variance) North African samples appeared
clearly separated from the European ones. The second component underlined the separation of
the Basque Country on one side, and the Middle Eastern samples on the other.
LD analyses
Different LD blocks were identified among populations. At first glance, Asian and Sub-Saharan
African samples showed different and characteristic LD patterns when compared with other
continental populations (S5–S8 Figs). Significant differences in LD structure for the 4 genomic
regions were observed in pairwise comparisons between Europe, Africa, and Asia (Table 1). A
more detailed analysis within continents indicated that only the 9p21 region showed signifi-
cantly different LD patterns in all subcontinental groups. Between North and South Europe the
LD blocks were not significantly different in the regions 1p13, 1q41 and 10q11.
Focusing only on SNPs previously associated with CAD, LD statistics (D’ and r2) for each
pair of risk SNPs and for each analysed population are provided in S4 Table. Risk SNPs in the
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same haplotype block (red colour in S4 Table) showed a high degree of variation in LD (0.35
D’1) in the populations analysed. The haplotype block information for these markers is pro-
vided in S5–S7 Tables for the 1p13, 9p21 and 10q11 regions, respectively.
The most remarkable differences in LD block structure were present in the 9p21 (Fig 3) and
10q11 regions (Fig 4). It is interesting to note the different positions shown by CAD associated
markers in Europe and North Africa. In the 9p21 region, associated markers in Europe (blue)
and in Caucasians together with African Americans or Chinese (black) laid at the beginning
of the region, whereas markers associated in North Africa (red) were located at the end (Fig 3).
In this region, the risk SNPs rs9632884, rs6475606, rs4977574, rs1537371, rs1333042, and
Fig 2. PC plot of the 22 population from Europe (circle), Middle East (circle) and North Africa (diamond) based on the variation of 190 independent
SNPs located in the CAD risk regions 1p13, 1q41, 9p21 and 10q11.
doi:10.1371/journal.pone.0134840.g002
Table 1. LD difference p-values for the 4 genomic regions analysed. Pairwise comparisons between North Europe (NEUR), South Europe (SEUR),
North Africa (NAFR), Sub-Saharan Africa (SAFR), and Asia.
1p13 NEUR SEUR NAFR SAFR 1q41 NEUR SEUR NAFR SAFR
SEUR 0.1740 - SEUR 0.6001 -
NAFR 0.0224 0.0005 - NAFR 0.0016 0.0156 -
SAFR 0.0096 0.0006 0.0328 - SAFR 0.0001 0.0001 0.0001 -
ASIA 0.0001 0.0001 0.0001 0.0001 ASIA 0.0489 0.1060 0.0034 0.0001
9p21 NEUR SEUR NAFR SAFR 10q11 NEUR SEUR NAFR SAFR
SEUR 0.0179 - SEUR 0.1193 -
NAFR 0.0001 0.0001 - NAFR 0.0001 0.0128 -
SAFR 0.0001 0.0001 0.0001 - SAFR 0.0001 0.0001 0.0001 -
ASIA 0.0001 0.0001 0.0001 0.0001 ASIA 0.0144 0.0032 0.0007 0.0001
doi:10.1371/journal.pone.0134840.t001
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rs1333049, located in the same haplotype block, were in tight LD in the European, North Afri-
can and Middle Eastern populations studied (0.831D’1) (S4 Table). On the other hand, in
the Sub-Saharan African, and Asian samples LD values ranged from 0.091 D’1 (grey in S4
Table). These SNPs were located in different haplotype blocks except in Tuscany and Andalu-
sia (S6 Table).
In the 10q11 genomic region, the three risk SNPs analysed (Fig 4) presented LD values in
the range of 0.772 D’1 in all the populations studied except in Sub-Saharan African and
Asian samples (0.035 D’1) (S4 Table). These three risk markers were located in the same
haplotype block in all the populations analysed except in Yoruba samples (S7 Table). Regarding
the 1p13 region (S9 Fig), the two risk markers, rs599839 and rs646776, presented high LD val-
ues in all the populations studied (D’>0.888) (S4 Table). These two risk factors were located in
the same haplotype block except in African populations (S5 Table).
The 1q41 genomic region showed previous associations with CAD only in samples of Euro-
pean origin and not in North Africans [10]. The most representative associated SNP in this
region was the rs17465637 [3] (S10 Fig).
Detection of potential signals of selection
The results of the locus by locus FST statistics and their significance as potential indicators
of selection are presented in S8 Table. In the European/Mediterranean area, 16 loci were
Fig 3. LD blocks for the region 9p21 in 26 populations from Europe, Africa and Asia.Markers previously associated with CAD only in Europe are
highlighted in blue, in Caucasians together with African Americans and Chinese in black and in North Africa in red.
doi:10.1371/journal.pone.0134840.g003
Fig 4. LD blocks for the region 10q11 in 26 populations from Europe, Africa and Asia.Markers previously associated with CAD only in Europe are
highlighted in blue and in North Africa in red.
doi:10.1371/journal.pone.0134840.g004
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potentially under selection (i.e. loci with significantly low or high FST values given their
heterozygosity). Out of these 16 loci, seven had high FST values (FST range = 0.067–0.094)
indicating potential positive selection and the other nine showed low FST values (FST range =
<0.0001–0.0004) suggesting balancing selection. Regarding cross-continental analyses, 15
loci were potentially under selection, eight of which indicated potential positive selection (FST
range = 0.248–0.293) and the other seven suggested balancing selection (FST range =<0.0001–
0.007).
The potential positively selected markers found in the above analyses (FST vs heterozygosity)
were a total of 14 and were located in regions 1p13, 1q41, and 9p21. Out of these 14 SNPs,
seven were found only in the context of the three continents, six only in Europe and North
Africa, and one in both groups (rs2811717 in the 9p21 region) (Fig 5). Fifteen markers located
in chromosomes 9 and 10 were potentially under balancing selection: six in the context of the
three continents, eight in Europe and North Africa and one in common (rs17155733 in the
10q11 region). The average allele frequency of these markers in the analysed populations is
of 0.50±0.35 (S2 Table). Consequently the possible influence of negative selection can be
discarded.
In the SPA analysis, three SNPs (rs9632884, rs1537371, and rs1333042) showed SPA
scores above the 99th percentile in each one of the sample group: North Africa (SPA value in
the 99th percentile: 0.87) and Europe (1.95) (S8 Table). None of these three North African
markers showed association with CAD in previous studies or was identified as being under
potential selective pressure in the previous tests. On the contrary, all three markers with the
highest SPA score in Europe were among the SNPs that showed signs of positive selection in
Europe and North Africa in the FST/HO tests. Also, these SNPs have been associated with CAD
in previous studies [34, 35, 36] and are located in the 9p21 genomic region: the CAD risk locus
most studied [37]. These three risk markers are in strong LD in most populations analysed (S4
Table). A geographical distribution of the MAF of one of these three SNPs, the rs1333042, in
the populations studied is represented in a smoothed spherical contour map in Fig 6.
Fig 5. Plot of FST values of the markers under potential positive selection found in the FST vs
heterozygosity analysis.On the left markers found only in the context of the three continents, on the right
markers found only in Europe and North Africa and in the middle (grey) the SNPs identified in both analyses.
doi:10.1371/journal.pone.0134840.g005
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The cross-continental FST and the EHH average tests, performed with the CEU, CHB and
YRI samples from the 1000 Genomes Selection Browser, pointed out markers in the extreme
5% of the genome-wide distribution. Markers with high FST values indicating potential positive
selection (top 2.5%) were identified in the four regions analysed (62 markers in the 1p13, 32 in
the 1q41, 121 in the 9p21, and 63 in the 10q11). Markers with extremely low FST values (bot-
tom 2.5%), indicating potential signatures of balancing selection, were also detected in all the
regions studied (13 in the 1p13, 3 in the 1q41, 42 in the 9p21, and 53 in the 10q11) (S9 Table).
After applying correction for multiple testing, seven markers with extremely high FST values
in the 9p21 region maintained their significance (red in S9 Table). These markers were located
in an 11-kb region (chr9: 21932366–21933125) and are not included in the 367 SNPs analysed
in the 26 populations. Comparing the FST estimated in the 26 populations analysed with the
1000 Genomes Browser Data, it is noteworthy the common signals detected for the rs2811717
in the 9p21 region (S8 Table). For this SNP the differences in cross-continental FST values
detected in the 26 population studied compared to the 1000 Genomes Browser data (0.29 vs.
0.65, respectively) are likely due to the different sets of populations included in each group
(S8 Table). Regarding the region 1p13, FST values of the three common markers detected in
both analyses (rs602633, rs583104, and rs599839) are very different comparing the 1000
Genomes data for CEU, CHB and YRI (0.57–0.59) with the 26 populations analysed (0.27–
0.29). Also in this case, this is likely due to the different populations included in the analysis,
mainly in the African continent (YRI alone versus 5 North African and 2 Sub-Saharan African
populations together). The EHH average test, used to validate the results found in the 9p21
region, showed potential signals of positive selection (p0.05) in the three populations ana-
lysed (grey in S10 Table). It is noteworthy the fact that the CAD risk marker rs1333042, which
showed potential signals of positive selection in the previous tests performed (FST vs HO. and
SPA score), is located in one of the 3-kb regions that show significant EHH values (region
Fig 6. Contour map of the MAF of the CAD risk SNP rs1333042 potentially positive selected in the 9p21 region.
doi:10.1371/journal.pone.0134840.g006
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highlighted in grey in S10 Table). However, no EHH average showed significant signals of
positive selection after correcting for multiple comparisons. Finally, concerning potential sig-
natures of balancing selection, the Tajima’s D analysis pointed out ten, five, and fourteen win-
dows with Tajima's D values above the 95th percentile (p0.05) of genome-wide distributions
in CEU (9p21), CHB (10q11) and YRI (10q11), respectively (S8 Table). Two regions were
found to overlap, a first between Asia and Sub-Saharan Africa in 10q11, for a 15 kb extension
and a second one across European samples in 9p21 for a 24 kb (S8 Table). Even though, after
applying corrections for multiple comparisons no windows showed significant signals of bal-
ancing selection.
The most relevant findings of positive selection regarding the 1p13, 1q41, and 9p21 genomic
regions, and of balancing selection of the regions 9p21 and 10q11 are summarized in Tables 2
and 3.
Discussion
This study explores for the first time the genetic diversity in four genomic regions associated
with CAD (1p13, 1q41, 9p21, and 10q11) through the genotyping of a set of European and
Mediterranean populations and using European, Asian and Sub-Saharan African data from the
1000 Genomes Project [11]. The main aim was to evaluate the relative importance of demogra-
phy and natural selection as a cause of population variability in some CAD risk regions identi-
fied in previous GWAS.
Diversity population indices indicate significant genetic structure in the context of the
three continents (FST = 0.085; p<0.0001) and also in Europe and in the Mediterranean area
(FST = 0.017; p<0.0001). The degree of genetic diversity observed in these four regions
between continents is comparable to that obtained from genome-wide genotyping and
sequencing studies [11, 38]. Moreover, in the European and Mediterranean context, these
Table 2. Significant positive selection results in a minimum of two different tests. Observed (Obs) FST with selection significance (highlighted P
value<0.01) for the three continents (Africa, Asia and Europe) and for Europe and North Africa. Global cross-continental FST scores in the CEU, CHB, and
YRI samples from the 1000 Genomes Selection Browser. Significant high and low FST values (extreme top 5% values of the distribution of FST values across
the genome) are highlighted in bold. P values were calculated on the basis of higher rank scores in the genomic distribution. SPA scores for continental Euro-
pean, and North African allele gradients (highlighted in bold SPA scores above 99th percentile).
Three
Continents
Europe and
North Africa
1000 Genomes
Browser
Europe North
Africa
Genomic
region
Position SNP_ID Obs FST FST P-
value
Obs FST FST P-
value
FST P_values SPA
scores
SPA
scores
1p13 109821307 rs583104 0.282 0.004 0.035 0.136 0.594 0.001 0.655 0.300
1p13 109821511 rs602633 0.293 0.002 0.034 0.151 0.592 0.001 0.596 0.312
1p13 109822166 rs599839 0.276 0.005 0.033 0.160 0.578 0.001 0.651 0.278
1q41 222839838 rs1053316 0.264 0.005 0.058 0.019 0.416 0.008 0.376 0.534
1q41 222844840 rs3008633 0.256 0.007 0.056 0.023 0.412 0.009 0.310 0.484
9p21 21920346 rs4977746 0.236 0.011 0.051 0.032 0.342 0.018 0.425 1.116
9p21 21930147 rs7864029 0.249 0.007 0.040 0.085 0.350 0.017 0.373 0.517
9p21 21931896 rs7869004 0.273 0.004 0.041 0.077 0.389 0.011 0.480 0.592
9p21 21946322 rs2811717 0.292 0.003 0.094 0.001 0.648 4.923E-
04
0.310 0.624
9p21 22072301 rs9632884 0.143 0.117 0.071 0.008 0.327 0.021 2.075 0.358
9p21 22099568 rs1537371 0.128 0.159 0.071 0.008 0.292 0.029 2.046 0.435
9p21 22103813 rs1333042 0.130 0.152 0.070 0.008 0.287 0.031 2.043 0.464
doi:10.1371/journal.pone.0134840.t002
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regions of epidemiological importance exhibit the same genetic variation pattern described
using sets of neutral markers (e.g. Alu insertion polymorphisms) and genome-wide arrays in
previous population studies [39, 40, 41, 42].
Regarding the LD haplotype blocks, this survey pointed to high levels of variation in LD and
sometimes to a different chromosomal location of CAD risk markers in populations of differ-
ent ancestry. The significant differences in LD structure found across European, North African,
Asian, and South African samples likely explain population differences in markers associated
to CAD across populations. These LD differences can be explained by the previously observed
trend of lower haplotype diversity and higher LD values when the geographic distance from
Africa increases, [43], in agreement with the Recent-African-Origin hypothesis [44].
Even though the general patterns of genetic variation are in agreement with the genetic
structure generated by demographic processes, we also observed potential signals of positive
and balancing selection in some specific markers and haplotypes. Seven SNPs under potential
positive selection showed association to diseases in previous studies [10, 24, 34, 35, 36, 45, 46,
47], whereas none of the markers under balancing selection was identified as a risk factor in
previous GWAS. Regarding the seven risk markers under positive selection, three of them are
located in the 1p13 region and four in 9p21. In the 1p13 region, two of the three markers
(rs602633 and rs583104) were associated with LDL-C [45, 46]. The other positively selected
SNP, rs599839, was associated with CAD in Caucasian populations [24]. These three markers
were detected in two of the selection tests performed (FST vs HO with 367 markers and FST
with the 1000 Genomes Selection Browser) in the context of three continents. The FST value
detected in the 1000 Genomes Data is in the same order of magnitude than recent positive
selection signals (FST>0.5) detected in previous studies performed on the lactase gene [48] and
on genome-wide scans [49].
The 9p21 genomic region, the most complex and studied CAD risk region [3], showed con-
sistent signals of positive selection. Indeed positive signatures of selection were identified in
each one of the four tests performed (FST vs HO, SPA score, FST and LRH test). The consistency
for selection signals in the 9p21 genomic region lies in the fact that these different tests are all
based on the same aspect of the data, i.e. population differentiation. Briefly, four variants
showed evidence of positive selection: rs9632884, rs6475606, rs1537371 and rs1333042. These
SNPs were previously associated with CAD [34, 35, 36, 47] and showed slightly different pat-
terns of LD blocks across populations.
Thanks to the high density of populations available for Europe and North Africa, we were
able to do a spatial analysis of selection (SPA test) in these geographic areas. Thus, the positive
signals of selection observed in the FST vs HO tests could be mainly attributed to Europeans. In
fact, the European SPA scores are higher than those detected in North Africans. Additionally,
the confirmation of three markers in the 9p21 genomic region (rs9632884, rs1537371, and
rs1333042) in two tests (FST vs HO and SPA score in Europe) is a good indicator of consistency
across our results. As an independent replication using the 1000 Genomes dataset, the region
containing one of these 3 markers (rs1333042) has shown a significant EHH value (before cor-
rection for multiple testing) in the LRH test. Moreover, this SNP, used as representative of the
other two risk markers, shows a South to North gradient of increase in MAF. The gradient
observed is in agreement with CAD incidence [50] and with previous genetic studies based on
the apolipoprotein E4 [51], or the genetic risk score of nitric oxide synthases [52], both associ-
ated with susceptibility to CAD. The South to North frequency gradient, in accordance with
CAD incidence rates, may be correlated with a potential selective role of CAD in the configura-
tion of genetic diversity in current human populations. On the contrary, another study showed
a geographical pattern opposite and uncorrelated with the disease incidence for genetics vari-
ants correlated with CAD [53]. The observed North to South cline in frequency detected in
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that work was likely due to the spatial distribution of the whole genome variation present in
the European continent, mainly shaped by demography. The potential positive selection signals
of the 9p21 region were also detected using the 1000 Genomes data. In fact, seven markers of
this region passed the multiple testing corrections in the FST tests showing FST values>0.78. In
addition is noteworthy the potential positive signal detected for the rs2811717 in the 26 popu-
lation studied and also in the 1000 Genomes Browser data. The FST value of this SNP in Europe
(0.094) is substantially higher than 0.028, value used to identify the most prominent genome-
wide candidate regions in a recent selection scan in Europe [54].
Regarding signatures of balancing selection, only the 9p21 and 10q11 regions showed evi-
dence of balancing selections in the Tajima’s D and in the FST vs HO tests. Although these
regions did not pass the corrections for multiple testing, it is noteworthy that regions of 15 kb
(encompassing five contiguous windows in 10q11) in Asian and African samples and 24 kb
(corresponding to eight contiguous windows in 9p21) in European populations showed evi-
dence of selection. The overlap in the signals observed for Asians and Africans in the 10q11
region suggests that this locus is likely subjected to selective processes in both populations, in
agreement with Wang et al. [55], who estimated that 78% of selective events are shared by two
or more populations. Regarding the 9p21 CAD risk region, the regions showing positive and
balancing selection are physically separated by a minimum of 11kb (the last positive selected
marker in the region: rs1333042 versus the first markers under balancing selection: rs2383206).
The two different natural selection signals seem to have population specificity arguing for dif-
ferent evolutionary processes behind the positive and balancing selection in the same genomic
region. While the plausible balancing selection signals found are acting mainly on European
populations (Tajima’s D test), the signals of positive selections in the region 9p21 involve the
three continents (FST and EHH tests).
The heterogeneity observed in the potential signals of natural selection in the different pop-
ulations analyzed might be correlated with environmental variables. A recent whole genome
scan reported evidence for selection on two markers implicated in cardiovascular disease by
identifying the SNPs with the strongest correlation between allele frequencies and climate,
specifically with winter solar radiation and summer precipitation rate in African and Western
Eurasian populations [56]. Another study enumerated several genes involved in the causal
pathways of atherosclerosis, that may be subject to various degrees of selective pressures result-
ing from climatic and dietary changes and host response to pathogens [57]. These pathways
may influence the genetic susceptibility to CAD and the heterogeneity observed in the signals
of selection among the populations analyzed.
Regarding CAD risk loci, the selection of harmful mutations may be due to the fact that
they are in LD with a relatively strong still unknown beneficial polymorphism [6] that could be
related to CAD. On the other hand, the positively selected loci could be related to other risk
traits since many GWAS SNPs are associated with more than one trait [58]. In the case of the
9p21 locus, several genetic variants had been associated with multiple cancers [59], glaucoma
[60], intracranial and abdominal aortic aneurysms [61], vascular dementia and late onset Alz-
heimer’s disease [62]. The response of a variant to selection is dependent also on the genetic
background. Due to pleiotropy, the existence of selection at a specific locus may be related to
different risk traits located in the same genomic region [58].
Although many selection scans have highlighted potentially interesting signals using
genome-wide SNP data, it is currently difficult to assess how much confidence should be placed
into them in the absence of clear signals of widespread, strong selection or of biological/func-
tional information [63]. Recent data suggests that it is unusual for selection factors to drive
new mutations rapidly to fixation in a specific population (the “hard sweep”model). A number
of possible theories have been proposed to explain these potential genome-wide selective
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signals. Among others, most selection on individual alleles may be relatively weak so that alleles
have not had time to sweep to fixation within continental populations. Moreover, the strength
of selection may vary temporally, and it may be rare for selection to be consistently strong for
the 10,000 years or more required to drive an allele close to fixation. Finally, much of human
adaptation may proceed by either polygenic adaptation or soft sweeps that can be difficult to
detect using standard methods [64]. This latter explanation (polygenic adaptation and/or soft
sweeps) may be especially relevant for complex traits, such as cardiovascular diseases, in which
several loci contribute to generate the disease. Current GWAS identified several common vari-
ants associated to CAD but at the moment there is an open debate about causal variants and
the role of rare variants [65, 66]. Consequently, the plausible signals of selection here found are
expected to be weak and difficult to be clearly identified. In this way, different novel method to
detect selection are needed to address potential confounding effects caused by population his-
tory and structure and to establish definitive evidence of selection, mechanism of selection, and
functional effects of the allelic variants under selection in complex traits.
One possible limitation of this survey is related to the ascertainment bias in the selection of
marker. The fact that these results were obtained by genotyping SNPs selected for specific crite-
ria (MAF higher than 0.05 and giving priority to markers not in LD in European populations),
and not through direct sequencing, could affect the found patterns of allele frequency, LD and
population differentiation [5]. It has been reported that the ascertainment bias introduced by
many methods of SNP discovery may have a large effect on the estimation of LD and recombi-
nation, influencing the decay of LD with distance [67]. Several studies reported significant LD
over distances longer than those predicted by standard models, whereas some data from short,
intergenic regions showed less LD than would be expected [68]. Indeed, loci containing high
frequency alleles tend to have deeper than average genealogies, providing more opportunity for
recombination, and thereby less LD. Regions in which many sequences are used for ascertain-
ment show more SNPs at low frequencies and a higher number of haplotypes are represented
in the data. In order to improve this bias, all the variation present in the 1000 Genomes Project
[11] for these genomic regions was used to perform the FST, the LRH and the Tajima’s D test.
The correspondence in the results across these two datasets with different marker coverage
(367 SNPs from our genotyping dataset and all the genetic variation from the 1000 Genomes
Project) allow us to consider the 9p21 genomic region as a potential candidate for positive and
balancing selection, and the 10q11 for balancing selection.
In the absence of additional functional information, our results are compatible with a poten-
tial selective role of CAD in shaping the genetic diversity observed in current human popula-
tions, but demographic processes cannot be discarded.
Supporting Information
S1 Dataset. Individual genotypes of the analysed data.
(XLSX)
S1 Fig. Genomic coordinates, genes included and genotyped SNPs for the region 1p13.
(TIF)
S2 Fig. Genomic coordinates, genes included and genotyped SNPs for the region 1q41.
(TIF)
S3 Fig. Genomic coordinates, genes included and genotyped SNPs for the region 9p21.
(TIF)
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S4 Fig. Genomic coordinates, genes included and genotyped SNPs for the region 10q11.
(TIF)
S5 Fig. LD blocks for the risk region 1p13 in 26 populations from Europe, Africa and Asia.
(TIF)
S6 Fig. LD blocks for the risk region 1q41 in 26 populations from Europe, Africa and Asia.
(TIF)
S7 Fig. LD blocks for the risk region 9p21 in 26 populations from Europe, Africa and Asia.
(TIF)
S8 Fig. LD blocks for the risk region 10q11 in 26 populations from Europe, Africa and
Asia.
(TIF)
S9 Fig. LD blocks for the risk region 1p13 in which markers previously associated with
CAD are located in 26 populations from Europe, Africa and Asia.Markers previously asso-
ciated in Europe are highlighted in blue.
(TIF)
S10 Fig. LD blocks for the risk region 1q41 in which markers previously associated with
CAD are located in 26 populations from Europe, Africa and Asia.Markers previously asso-
ciated in Europe are highlighted in blue.
(TIF)
S1 Table. Geographic origin, population codification, sample size and geographic coordi-
nates in decimal degrees for the population samples.
(XLSX)
S2 Table. Allele frequencies and heterozygozities (mean and standard deviation (SD)) per
marker and per population.
(XLSX)
S3 Table. Reynolds’s genetic distances estimated among North European and Mediterra-
nean populations based on the SNPs located in the 1p13, 1q41, 9p21, and 10q11 CAD risk
regions.
(XLSX)
S4 Table. LD statistics (D’ and r2) for each pair of risk SNPs and for each population ana-
lysed. Risk SNPs in the same haplotype are highlighted in red. Risk SNPs in the same haplotype
block in LD (D’ = 1) are highlighted in grey.
(XLSX)
S5 Table. Haplotype block data for the 1p13 region based on the S9 Fig. CAD risk SNPs are
highlighted in grey and their number corresponds to the risk markers in S9 Fig.
(XLSX)
S6 Table. Haplotype block data for the 9p21 region based on the Fig 3. CAD risk SNPs are
highlighted in grey and their number corresponds to the risk markers in Fig 3.
(XLSX)
S7 Table. Haplotype block data for the 10q11 region based on the Fig 4. CAD risk SNPs are
highlighted in grey and their number corresponds to the risk markers in Fig 4.
(XLSX)
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S8 Table. Detection of selection results for the four genomic regions analysed (1p13, 1q41,
9p21 and 10q11).Observed (Obs) FST with selection significance (highlighted P value<0.01)
for the three continents (Africa, Asia and Europe) and for Europe and North Africa. Global
cross-continental FST scores in the CEU, CHB, and YRI samples from the 1000 Genomes Selec-
tion Browser. Significant high and low FST values (extreme top 5% values of the distribution of
FST values across the genome) are highlighted in grey. P values were calculated on the basis of
higher rank scores in the genomic distribution. SPA scores for continental European, and
North African allele gradients (highlighted in grey SPA scores above 99th percentile). Tajima’s
D test results in the CEU, CHB, and YRI samples of the 1000 Genomes Project. Signals of
potential balancing selection (P value0.05) are highlighted in grey. P-values were calculated
on the basis of higher rank scores in the genomic distribution of Tajima’s D values.
(XLSX)
S9 Table. Global cross-continental FST scores in the CEU, CHB, and YRI samples of the
1000 Genomes Project. Significant high and low FST values (above the top 5% extreme values
of the distribution of FST values across de genome) are highlighted in grey. P values were calcu-
lated on the basis of higher rank scores in the genomic distribution. Significant FST values after
applying correction for multiple testing are highlighted in red.
(XLSX)
S10 Table. EHH averages in the CEU, CHB, and YRI samples of the 1000 Genomes Project.
Significant high EHH values (above the top 5% extreme values of the distribution of EHH val-
ues across de genome) are highlighted in grey. The region containing the CAD risk marker
rs1333042 is highlighted in grey. P values were calculated on the basis of higher rank scores in
the genomic distribution.
(XLSX)
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